Soleno Therapeutics, Inc. (SLNO)
52.66
+0.02
(+0.04%)
USD |
NASDAQ |
Apr 14, 10:11
Soleno Therapeutics Cash from Investing (TTM) : -201.78M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Neurocrine Biosciences, Inc. | -264.40M |
| Nektar Therapeutics | -1.197M |
| Boston Scientific Corp. | -2.64B |
| Integer Holdings Corp. | -270.73M |
| Molina Healthcare, Inc. | 312.00M |